- Home
- ATOS vs SPCE Comparison
ATOS vs SPCE Comparison
Compare ATOS & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- SPCE
- Stock Information
- Founded
- ATOS 2009
- SPCE 2017
- Country
- ATOS United States
- SPCE United States
- Employees
- ATOS N/A
- SPCE N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- SPCE Transportation Services
- Sector
- ATOS Health Care
- SPCE Consumer Discretionary
- Exchange
- ATOS Nasdaq
- SPCE Nasdaq
- Market Cap
- ATOS 174.8M
- SPCE 177.2M
- IPO Year
- ATOS 2012
- SPCE N/A
- Fundamental
- Price
- ATOS $1.54
- SPCE $7.15
- Analyst Decision
- ATOS Strong Buy
- SPCE Hold
- Analyst Count
- ATOS 3
- SPCE 6
- Target Price
- ATOS $6.25
- SPCE $25.50
- AVG Volume (30 Days)
- ATOS 502.2K
- SPCE 1.8M
- Earning Date
- ATOS 11-19-2024
- SPCE 11-06-2024
- Dividend Yield
- ATOS N/A
- SPCE N/A
- EPS Growth
- ATOS N/A
- SPCE N/A
- EPS
- ATOS N/A
- SPCE N/A
- Revenue
- ATOS N/A
- SPCE $9,416,000.00
- Revenue This Year
- ATOS N/A
- SPCE N/A
- Revenue Next Year
- ATOS N/A
- SPCE N/A
- P/E Ratio
- ATOS N/A
- SPCE N/A
- Revenue Growth
- ATOS N/A
- SPCE 93.74
- 52 Week Low
- ATOS $0.62
- SPCE $5.27
- 52 Week High
- ATOS $2.31
- SPCE $54.60
- Technical
- Relative Strength Index (RSI)
- ATOS 65.98
- SPCE 59.26
- Support Level
- ATOS $1.36
- SPCE $6.07
- Resistance Level
- ATOS $1.66
- SPCE $7.70
- Average True Range (ATR)
- ATOS 0.07
- SPCE 0.51
- MACD
- ATOS 0.02
- SPCE 0.03
- Stochastic Oscillator
- ATOS 80.65
- SPCE 89.44
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.